Anifrolumab for heart health in lupus patients
Treatments studied
Part of Heart & circulation, Immune system & allergy, Skin clinical trials.
This study tests whether anifrolumab, a drug that targets the immune system, can improve markers of blood vessel health in people with lupus. It may help reduce the risk of heart problems associated with lupus.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with lupus (SLE).
- You are on a stable dose of prednisone (10 mg/day or less) for at least 2 weeks before the study starts.
- You have abnormal blood vessel stiffness or inflammation, as measured by a special test (CAVI, PWV, or PET scan).
- You are willing to use effective contraception if you or your partner can become pregnant.
- You have been vaccinated against COVID-19 and shingles (varicella zoster).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
This study looks at potential risks of the lupus medication anifrolumab in people with moderate to severe SLE. It focuses on serious infections and malignancies to see how safe the treatment is.
This study tests an experimental drug called anifrolumab, which is given as an injection or infusion, to see how it works in people with active lupus. It may help reduce lupus symptoms by targeting the immune system.
This study tracks how well anifrolumab works and how safe it is for people with active lupus. It's a real-world look at the drug's effects, so no additional treatments or tests are required beyond what your doctor already prescribes.
This study tests whether a medicine called anifrolumab can help reduce severe tiredness (fatigue) in people with lupus. It is for adults whose lupus is mostly under control but who still feel very tired.
This study tests whether an intravenous medicine called anifrolumab can safely improve active systemic lupus (SLE) in children. If you qualify, you may receive the study treatment and be closely monitored for safety and lupus symptoms.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.